Pharmaceutical companies are shifting focus from weight loss to tackling brain disorders such as Alzheimer's and Parkinson's with drugs like Ozempic. The United States is experiencing a surge in prescriptions for anti-obesity drugs, particularly Ozempic, with high demand exceeding supply. Doctors have witnessed significant transformations in patients' lives, including substantial weight loss and canceled surgeries.
Weight loss drugs like Ozempic are booming in America. Last year, U.S. demand for these drugs, known as GLP-1 agonists, exceeded supply. Here's what we do — and don't — know about them so far. https://t.co/odZWWuXTfr
To be clear, I have been prescribing Ozempic for weight loss for 4 years now When I told other docs about them they laughed at me. Some didn’t know what it was But I’ve had people COMPLETELY transform their lives - 100 lbs lost - Knee replacement surgeries cancelled - new… https://t.co/gohSiMHTJZ
Weight loss drugs like Ozempic are booming in America. Last year, U.S. demand for these drugs, known as GLP-1 agonists, exceeded supply. Here's what we do — and don't — know about them so far. https://t.co/l729Hrs1ND
United States of Ozempic: Where anti-obesity drugs are taking off https://t.co/ikxzrOuVzz
Where anti-obesity drugs are taking off https://t.co/pMss0XzS7e
US states most hooked on Ozempic REVEALED: Map shows where weight- loss shot is most commonly doled out https://t.co/APcyMHcRQZ https://t.co/VNT8wtPGp6
United States of Ozempic: Where prescriptions for anti-obesity drugs are taking off https://t.co/mhcVaZVEIW
United States of Ozempic: Where anti-obesity drugs are taking off https://t.co/1HJb7oW8x6 @TreedinDC
Big pharma companies, armed with billions of dollars in sales, are now on a mission to eliminate obesity altogether. #ObesityRevolution https://t.co/WaWGcQ5vrn
People taking Ozempic will eventually stop losing weight. But could more powerful drugs help them get to a lower weight-loss plateau? @sarahzhang reports: https://t.co/2DynsreKOT
Ozempic and similar drugs approved for weight loss—are already set for the next chapter: tackling a wide range of brain disorders, including Alzheimer’s and Parkinson’s https://t.co/6zDl9UE4mv